Successful treatment of chronic recurrent life‐threatening bleeding due to an acquired factor V Inhibitor with rituximab and steroids
Author:
Affiliation:
1. UF Health Cancer Center at Orlando Health Orlando FL USA
Publisher
Wiley
Subject
Genetics(clinical),Hematology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.12915
Reference5 articles.
1. Factor V deficiency: a concise review
2. Acquired factor V inhibitor
3. Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study
4. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
5. ITP and TTP: interpreting evidence in light of patient values
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acquired factor V inhibitor with erythema and eosinophilia in a patient with end-stage renal disease;CEN Case Reports;2022-08-09
2. Acquired factor V inhibitor: Success of steroids in a patient with primary sclerosing cholangitis, ulcero haemorragic rectocolitis, biological Biermer's disease;Transfusion Clinique et Biologique;2021-05
3. Successful Management of Life-threatening Pelvic Hemorrhage From Acquired Factor V Deficiency With immunosuppressive Therapy;Cureus;2020-08-23
4. Plasma Exchange as an Initial Treatment for Severe Bleeding Induced by Acquired Factor V Deficiency: A Case Report and Mini Literature Review;Acta Haematologica;2020-08-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3